In his presentation, Dr. Erkin Aribal from Acibadem University in Istanbul showed results of a national study suggesting AI could reduce interval cancer rates, in case AI is applied as a second or third independent reader.

“Middle-income countries have limited human and financial resources for a screening program,” Aribal said. “AI as a second reader can be beneficial for reducing interval cancers and contribute to insufficiencies.”

Interval breast cancers tend to have a less favorable prognosis than screen-detected cancers and are more likely to be of higher grade and stage. One…